Chemical Structure (Darifenacin 01)
Darifenacin
Product Images NDC 70754-161
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Darifenacin (NDC 70754-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Alan Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Darifenacin 02)
This text provides a chart showing the mean (SD) darifenacin plasma concentration (ng/mL) at different time points post-dose in hours. The chart displays data points at 4, 8, 12, and 16 hours.*
Figure 2a (Darifenacin 03)
Figure 2b (Darifenacin 04)
Figure 2c (Darifenacin 05)
The text provides a graph showing the median reduction in incontinence episodes per week from the baseline, along with its 95% confidence level, over a period of time referred to as "weeks." The graph is part of Study 3 and is labeled as Figure 2¢. No further information is available from this text.*
Principal Display Panel (7.5 mg 30 Tablet Bottle Label)
This is a medication called "Darifenac," with extended-release tablets containing 1mg per tablet. The typical dosage is not provided. It is recommended to keep this medication out of the reach of children and to store it between 15 to 30° C (59 to 86° F), protected from light. The product has a lot number and an expiration date.*
Principal Display Panel (7.5 mg 500 Tablet Bottle Label)
This text appears to be a label for a medication called Darifenac, which comes in the form of tablets containing 7.5 mg of the active ingredient darifenacin hydrobromide. The label provides information about the dosage and storage instructions for the drug, as well as a warning to keep it out of reach of children. The lot number and expiration date are also included.*
Principal Display Panel (15 mg 30 Tablet Bottle Label)
This appears to be a description of a medication called Darifenacin hydrobromide, which is available in tablet form. Each tablet contains 15 mg of Darifenacin hydrobromide and the recommended dosage is one tablet. The medication should be stored at 25° C (77° F) and protected from light. The lot number and expiration date are also provided.*
Principal Display Panel (15 mg 500 Tablet Bottle Label)
This appears to be a label for a medication containing 15mg of darifenaci per tablet. The recommended dosage is not available. It gives instructions to keep the drug out of the reach of children and store it at a temperature range of 15 to 30 degrees Celsius to protect it from light. The label includes a lot number and expiration date of the medication.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
